264 related articles for article (PubMed ID: 19106612)
1. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions.
Santiago A; Godsey AC; Hossain J; Zhao LY; Liao D
Cell Cycle; 2009 Jan; 8(1):76-87. PubMed ID: 19106612
[TBL] [Abstract][Full Text] [Related]
2. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation.
Chang CC; Naik MT; Huang YS; Jeng JC; Liao PH; Kuo HY; Ho CC; Hsieh YL; Lin CH; Huang NJ; Naik NM; Kung CC; Lin SY; Chen RH; Chang KS; Huang TH; Shih HM
Mol Cell; 2011 Apr; 42(1):62-74. PubMed ID: 21474068
[TBL] [Abstract][Full Text] [Related]
5. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1.
Cappadocia L; Mascle XH; Bourdeau V; Tremblay-Belzile S; Chaker-Margot M; Lussier-Price M; Wada J; Sakaguchi K; Aubry M; Ferbeyre G; Omichinski JG
Structure; 2015 Jan; 23(1):126-138. PubMed ID: 25497731
[TBL] [Abstract][Full Text] [Related]
7. DAXX in cancer: phenomena, processes, mechanisms and regulation.
Mahmud I; Liao D
Nucleic Acids Res; 2019 Sep; 47(15):7734-7752. PubMed ID: 31350900
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45.
Sekiyama N; Arita K; Ikeda Y; Hashiguchi K; Ariyoshi M; Tochio H; Saitoh H; Shirakawa M
Proteins; 2010 May; 78(6):1491-502. PubMed ID: 20077568
[TBL] [Abstract][Full Text] [Related]
9. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
[TBL] [Abstract][Full Text] [Related]
10. SUMO regulates the cytoplasmonuclear transport of its target protein Daxx.
Chen A; Wang PY; Yang YC; Huang YH; Yeh JJ; Chou YH; Cheng JT; Hong YR; Li SS
J Cell Biochem; 2006 Jul; 98(4):895-911. PubMed ID: 16475184
[TBL] [Abstract][Full Text] [Related]
11. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
12. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
13. Modification of Daxx by small ubiquitin-related modifier-1.
Jang MS; Ryu SW; Kim E
Biochem Biophys Res Commun; 2002 Jul; 295(2):495-500. PubMed ID: 12150977
[TBL] [Abstract][Full Text] [Related]
14. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
15. SUMO E3 ligase activity of TRIM proteins.
Chu Y; Yang X
Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation.
Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T
J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774
[TBL] [Abstract][Full Text] [Related]
17. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
18. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
19. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
20. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
